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Ewing’s sarcoma (ES) is the second most common primary sacral tumor. ES are aggressive 
tumors with a tendency toward recurrence following resection and pronounced proclivity toward 
hematogenous metastasis to lungs and bone. 
A 52-year-old woman presented with of pain in her right posterior thigh radiating to the back 
of the knee. A magnetic resonance imaging showed an irregularly shaped right presacral mass. 
A core needle biopsy revealed a small, round blue cell neoplasm suggestive of a primitive 
neuroectodermal tumor. Staging workup with whole body Positron emission tomography (PET) 
showed no other area of abnormally increased uptake of fluorodeoxyglucose. After four cycles of 
therapy and radiotherapy repeat pelvic MRI, CT and PET scan showed significant shrinkage of 
the mass and normalization of fluorodeoxyglucose uptake. Six weeks later the patient presented 
with acute shortness of breath and PET-CT demonstrated increased uptake within bilateral 
pulmonary hila suggestive of metastatic disease. A subsequent biopsy of the lung confirmed the 
metastatic ES.
This case report demonstrates that despite adequate control of the local disease, multimodal 
therapy did not appear to effect metastasis. Although the recent Inter-group study suggested that 
the addition of IE to traditional regimens may confer a local control benefit, the use of IE was not 
associated with improved event-free survival. This raises the possibility that micrometastases had 
pre-dated the onset of chemotherapy and even went undetected by PET scanning.
